Amber joined cc-TDI while pursuing her Ph.D. in Cell and Developmental Biology in the laboratory of Michael Heinrich at Oregon Health & Science University. She studies a subset of Gastrointestinal Stromal Tumors that specifically affects the pediatric population. As a scientist, her goal is to have her lab research be directly translated into clinic. In 2015, she was awarded an OCTRI scholarship aimed at educating graduate students in clinical and translation research. Amber is also enrolled in University of Portland’s Technology Entrepreneurship Program which focuses on commercialization potential and feasibility of bioscience technologies. After graduation, Amber plans to be involved in business development to facilitate the process of turning bench-side experiments into tangible and meaningful results in the clinic.
Scientific Director & Chief Mission Officer